Pharmacology & Pharmacy

Vol.4 No.9(2013), Paper ID 40663, 5 pages

DOI:10.4236/pp.2013.49094

 

Evolution of Biochemical Effects of Byetta® in Type 2 Diabetics with Cardiovascular Risk

 

Alfonso López Ruiz, María Ángeles Ibáñez Gil, Pedro Pujante Alarcón, Alicia Hernández Torres, Ana Belen Hernández Cascales, María Dolores Hellín Gil

 

Pharmaceutical Care Research at the University of Granada, Granada, Spain;
Health Center Mariano Yago, Yecla, Murcia, Spain;
Endocrinology and Nutrition Service of the Hospital University Virgen de la Arrixaca, Murcia, Spain
Infectious Internal Medicine of the Hospital University Virgen de la Arrixaca, Murcia, Spain.
Endocrinology and Nutrition Service of the Hospital University Virgen de la Arrixaca, Murcia, Spain;
Endocrinology and Nutrition Service of the Hospital University Virgen de la Arrixaca, Murcia, Spain;

 

Copyright © 2013 Alfonso López Ruiz, María Ángeles Ibáñez Gil, Pedro Pujante Alarcón, Alicia Hernández Torres, Ana Belen Hernández Cascales, María Dolores Hellín Gil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


A. López Ruiz, M. Gil, P. Alarcón, A. Torres, A. Cascales and M. Gil, "Evolution of Biochemical Effects of Byetta® in Type 2 Diabetics with Cardiovascular Risk," Pharmacology & Pharmacy, Vol. 4 No. 9, 2013, pp. 679-683. doi: 10.4236/pp.2013.49094.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.